- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06097923
Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU)
Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer of Postoperative Patients in Surgical Intensive Care Unit (SICU); a Novel Guidance to Set an Ideal Fluid Status of Patient in Acute Postoperative Phase
Study Overview
Status
Conditions
Detailed Description
Critically ill patients admitted to an intensive care unit (ICU) after surgery have commonly experienced a large amount of wide organ injury and profuse bleeding resulting in vessel damage during surgery. Severe systemic inflammatory reactions and pathophysiological stress could consequently occur in these patients. For patients in an acute postoperative phase, it is important to maintain organ perfusion by correcting hemodynamic instability through fluid resuscitation.
Bioelectrical impedance analysis (BIA), a non-invasive method, is useful for quantitatively measuring body composition such as body fat and muscle mass. It is also useful for evaluating volume status based on resistance and reactance of cells known to have different electrical conductivity according to biological characteristics of body composition. In our previous study using BIA, the results showed that changes in ECW ratio after surgery were related to conventional parameters of overhydrated status such as daily fluid balance or capillary leak index (CLI). In addition, overhydration with value of ECW ratio above 0.390 on 3rd postoperative day appeared to be a risk factor for postoperative morbidity and mortality.
Herein, we aim to set the ECW ratio as a guideline for postoperative volume status and confirm a hypothesis that active intervention with fluid management to control the ECW ratio by BIA could lower clinical outcomes in patients with fluid imbalance through a prospective randomized controlled study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Seocho-gu, Banpo-dong Banpodaero 222
-
Seoul, Seocho-gu, Banpo-dong Banpodaero 222, Korea, Republic of, 137-701
- Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients admitted to the surgical ICU after surgery under general anesthesia regardless of the type of surgery
- Patients who showed abnormal range of baseline ECW ratio by BIA (less than 0.390 or more than 0.405) that measured at the time of ICU admission
Exclusion Criteria:
- aged under 18 years
- underwent surgery under local or regional anesthesia
- pregnant
- had bone fixation or underwent limb amputation
- had any prosthetic medical devices such as pacemaker or metallic intravascular device
- stayed in ICU for less than 48 hours
- readmitted within 48 hours after ICU discharge
- diagnosed with renal failure and receiving renal replacement therapy
- underwent extracorporeal membrane oxygenation treatment before surgery
- agreed for do-not-resuscitate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active fluid management with BIA monitoring
For assessment of fluid status, a commercial portable BIA device (InBody M20®, InBody Corp., Seoul, Korea) was measured.
Baseline BIA data were collected at the time of ICU admission, and BIA measurements were performed daily for 3days for all participants.
The participants in active fluid management with BIA monitoring arm received fluid supplementation targeting specific range of ECW ratio by BIA (0.390-0.406).
If a patient with dehydrated status indicated by the ECW ratio was less than 0.390, a bolus infusion was performed using 250ml of crystalloid fluid (PlasmaLyte).
If a patient with overhydrated status indicated by the ECW ratio was more than 0.406, 10mg of furosemide was administered.
Changes in the ECW ratio were measured at one hour after initial intervention for fluid adjustment, and the investigators determined whether additional intervention was needed according to results of changes.
These processes continued until the ECW ratio was within the normal range (0.390-0.406).
|
The participants in active fluid management with BIA monitoring arm received fluid supplementation targeting specific range of ECW ratio by BIA (0.390-0.406).
If a patient with dehydrated status indicated by the ECW ratio was less than 0.390, a bolus infusion was performed using 250ml of crystalloid fluid (PlasmaLyte).
If a patient with overhydrated status indicated by the ECW ratio was more than 0.406, 10mg of furosemide was administered.
Changes in the ECW ratio were measured at one hour after initial intervention for fluid adjustment, and these processes continued until the ECW ratio was within the normal range (0.390-0.406).
|
|
Experimental: Conventional fluid management without BIA monitoring
For assessment of fluid status, a commercial portable BIA device with 5-kilohertz, 50-kilohertz, and 250-kilohertz alternating current (InBody M20®, InBody Corp., Seoul, Korea) was measured. Baseline BIA data were collected at the time of ICU admission. Thereafter, BIA measurements were performed daily for 3 days for all participants. The participants in conventional fluid management without BIA monitoring arm underwent conventional fluid management without specific targets of ECW ratio by BIA. |
The participants in conventional fluid management without BIA monitoring arm underwent conventional fluid management without specific targets of ECW ratio by BIA.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
In-hospital mortality rate
Time Frame: Participants were followed upto 28th day after surgery
|
Proportion of patients who died during the hospitalization period among participants
|
Participants were followed upto 28th day after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of postoperative morbidities
Time Frame: Participants were followed upto 28th day after surgery
|
Proportion of patients who experienced postoperative complications among participants
|
Participants were followed upto 28th day after surgery
|
|
28-day mortality rate
Time Frame: Participants were followed upto 28th day after surgery
|
Proportion of patients who died within 28 days after surgery among participants
|
Participants were followed upto 28th day after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BIA_03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fluid Overload
-
Nordsjaellands HospitalRigshospitalet, Denmark; University of CopenhagenRecruitingFluid Therapy | Fluid Overload | Fluid AccumulationSpain, Denmark, India, United Kingdom, Finland, Iceland, Lithuania, New Zealand, Norway, Sweden, Switzerland
-
Jagiellonian UniversityCompletedFluid Overload | Fluid LossPoland
-
Uppsala UniversityCompletedFluid Therapy | Fluid Overload | Critical CareSweden
-
Nuwellis, Inc.AKI Critical Care Research FoundationTerminatedFluid OverloadUnited States
-
Hospices Civils de LyonRecruiting
-
Morten H. BestleUniversity of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention... and other collaboratorsRecruitingFluid OverloadDenmark, Netherlands, Switzerland, Finland, Iceland, Norway, Australia
-
Nova Scotia Health AuthorityWithdrawnFluid OverloadCanada
-
All India Institute of Medical Sciences, RishikeshCompleted
-
Medical University of ViennaCompleted
Clinical Trials on Active fluid management with BIA monitoring
-
Twin Star Medical, Inc.United States Department of DefenseUnknownCompartment SyndromeUnited States
-
Korea University Guro HospitalSoonchunhyang University HospitalRecruitingHeart Failure,CongestiveKorea, Republic of
-
University Health Network, TorontoCompleted
-
Duke UniversityNational Cancer Institute (NCI)CompletedDuctal Carcinoma in SituUnited States
-
Bradley MarinoNot yet recruitingHypotension During Surgery | Hypotension PostproceduralUnited States
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Fordham UniversityAlbert Einstein College of Medicine; University of Texas at Austin; William Marsh...CompletedSmoking CessationUnited States
-
Northwestern UniversityOmron Healthcare Co., Ltd.Completed
-
Ohio State UniversityIRRASRecruitingSubarachnoid Hemorrhage | Intraventricular Hemorrhage | Ventriculitis | Subdural HematomaUnited States
-
The First Affiliated Hospital of Guangzhou Medical...Guangdong Provincial Hospital of Traditional Chinese Medicine; Guangzhou First... and other collaboratorsRecruitingCOPD | Hypercapnic Respiratory FailureChina